US 9133480
Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites
granted A61KA61K2039/5256A61K39/285
Quick answer
US patent 9133480 (Recombinant modified vaccinia ankara (MVA) vaccinia virus containing restructured insertion sites) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/5256, A61K39/285, A61P, A61P31/14